BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
GMATBootcamp Starts Sep 28
Chris Peckover, Target Test Prep GMAT expert
LIVE ONLINE BOOTCAMP

Live Online Bootcamp Class with Top GMAT Expert Chris Peckover

15 live classes from Sep 28, 2026

Schedule
Mon to Fri · 7:00 to 10:00 PM ET
Included
Live classes + 6 months of TTP OnDemand
  • Boost your GMAT score in less than one month in a live online class
  • 6 months access to TTP OnDemand video courses included
View bootcamp & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Blood banks

Expert replies
by freakomalay » Mon May 25, 2009 12:29 am
Blood banks will shortly start to screen all donors for NANB hepatitis. Although the new screening tests are estimated to disqualify up to 5 percent of all prospective blood donors, they will still miss two-thirds of donors carrying NANB hepatitis. Therefore, about 10 percent of actual donors will still supply NANB-contaminated blood.

19. The argument above depends on which of the following assumptions?
(A) Donors carrying NANB hepatitis do not, in a large percentage of cases, carry other infections for which reliable screening tests are routinely performed.
(B) Donors carrying NANB hepatitis do not, in a large percentage of cases, develop the disease themselves at any point.
(C) The estimate of the number of donors who would be disqualified by tests for NANB hepatitis is an underestimate.
(D) The incidence of NANB hepatitis is lower among the potential blood donors than it is in the population at large.
(E) The donors who will still supply NANB-contaminated blood will donate blood at the average frequency for all donors.
AIMing 700+ ..............
Join the discussion
Source: — Critical Reasoning |

by scoobydooby » Mon May 25, 2009 2:23 am
would go for C

A. infections other than NAND hepatitis is out of scope

B. whether donors develop the disease is out of scope

C. by POE.

D. incidence of hepatitis is out of scope. the stimulus talks about carriers of the hepatitis virus

E. frequency of donating blood is out of scope.
Join the discussion

by rahulg83 » Mon May 25, 2009 7:10 am
I second C
Join the discussion

by Musicolo » Mon May 25, 2009 7:21 am
either C or E, but I would go for E.
Join the discussion

by 2010gmat » Mon May 25, 2009 10:53 am
IMO A

wat if NANB affected donors also have other infections?? they will be screened ...
Join the discussion

by tdadic84 » Mon May 25, 2009 10:59 am
2010gmat...other infections are out of scope...
Join the discussion

by axat » Mon May 25, 2009 11:15 am
I will go with B.
Because they do not develop the disease, the testing will not identify them as carriers of the virus. This is what is implied.

What's the OA?

A- outta scope. Who cares about other diseases!
C- assuming this is a bit of a stretch.
D- outta scope
E- the frequency won't affect the percentage.
Join the discussion

by vinaynp » Mon May 25, 2009 2:18 pm
The OA is [spoiler] A) [/spoiler] and I agree with 2010gmat.

We can infer that 15% of the donors carry NANB hepatitis.
5% of the donors carrying NANB hepatitis will be screened by the tests.

Hence, 10% of the donor carrying NANB hepatitis will not be screened. For this to be true, these 10% of the donors should not be screened by any other tests.

Hence, A) is correct.
Join the discussion

by james33 » Sun May 15, 2016 7:46 pm
I think E is the right answer here
Join the discussion